Sep 2026
ROS-responsive bionanodrug for atherosclerosis therapy via regulating glycolipid metabolism and cell crosstalk.
Jie Yu, Xiao-Yan Dong, Fei-Fei Yu et al.
· Journal of Controlled Releas... · 0 citations